Clinical Trials Directory

Trials / Unknown

UnknownNCT02134093

Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients

Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients -a Single-center, Randomized ,Double-blinded and Controlled Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Tang-Du Hospital · Academic / Other
Sex
All
Age
55 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is to explore the effects of dexmedetomidine on postoperative cognitive dysfunction during one-lung ventilation in elder patients.

Conditions

Interventions

TypeNameDescription
DRUGInduction of anesthesia,midazolam ,sufentanil,etomidate and rocuroniumAnesthesia induction:midazolam (0.03\~0.05 mg/kg), sufentanil(0. 5\~0.8 μg/kg), etomidate ( 0.2\~0.6mg/kg) and rocuronium(0.6mg/kg)
DRUGDexmedetomidineContinuous pump infusion dexmedetomidine at 0.5μg/kg (low dose group)or 1μg/kg (high dose group)for 15 minutes before anesthesia induction,then followed by a continuous pump infusion at 0.2 μg/kg/h(low dose group)or 0.4μg/kg/h(high dose group) until the end of surgery.
DRUGNormal salineContinuous pump infusion normal saline with identical volume of dexmedetomidine.
DRUGMaintenance of anesthesia , propofol, remifentanil,vecuroniumContinuous infusion of propofol (3\~6 mg/kg/h), remifentanil (0.05\~0.3 μg/kg/min)is required to maintain Entropy within 40\~60,Mean Arterial Blood Pressure more than 20% of baseline level , Oxygen Saturation more than 90% , airway pressure less than 40 cm H2O, intermittent injection vecuronium (0.05\~0.1mg/kg) as needed to maintain muscle relaxation.

Timeline

Start date
2014-07-01
Primary completion
2015-05-01
Completion
2015-12-01
First posted
2014-05-08
Last updated
2014-07-11

Source: ClinicalTrials.gov record NCT02134093. Inclusion in this directory is not an endorsement.